Supports investigator-initiated clinical trials for neurological disorders, from early exploratory studies to Phase 3 confirmatory and comparative effectiveness trials.
This grant has transitioned from forecasted to posted and is now accepting applications.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.
Funding support available to study and prove effectiveness of potential neurotherapeutic agents for neurological disorders towards further development.
Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.
NIH StrokeNet seeks clinical trials and biomarker studies for stroke treatment, recovery, and prevention, offering infrastructure support for selected projects.